SPECIFIC PHARMA A/S: Financial statements 2019
CVR: 33161395
Source: annual report 2019, Danish Business Authority
01/02/2018 – 31/01/2019
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 146,427,000 and a net result of DKK 8,914,000 compared with DKK 14,821,000 the year before. That is an increase of 0.5% compared with the year before. The profit margin was 6.1%. Equity in the 2019 report amounted to DKK 78,648,000. The solvency ratio was 84.5%. The company had 15 employees in the financial year.
- Revenue
- DKK 146,427,000
- Gross Profit
- DKK 25,310,000
- Profit/Loss
- DKK 8,914,000
- Equity
- DKK 78,648,000
- Total Assets
- DKK 93,125,000
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 146.4 mio. | 25.3 mio. | 8.9 mio. | 78.6 mio. | 15 |
| 2018 | 145.7 mio. | 29.7 mio. | 14.8 mio. | 69.7 mio. | 12 |
| 2017 | 142.4 mio. | 41.9 mio. | 26.2 mio. | 74.6 mio. | 8 |
| 2016 | 141.1 mio. | - | 20.2 mio. | 63.5 mio. | 8 |
| 2015 | 132 mio. | 35.9 mio. | 24.1 mio. | 61.4 mio. | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of August 27, 2019, Ken Rasmussen has joined the board of directors of SPECIFIC PHARMA A/S.
As of June 13, 2019, Ole Markussen has joined the board of directors of SPECIFIC PHARMA A/S.
As of May 2, 2019, Ole Markussen has stepped down as adm. dir. of SPECIFIC PHARMA A/S.
As of May 1, 2019, Uffe Kåre Jensen is registered as adm. dir. of SPECIFIC PHARMA A/S.
As of January 3, 2019, Samia Sofie Kappe has stepped down as adm. dir. of SPECIFIC PHARMA A/S.
As of January 1, 2019, Ole Markussen is registered as adm. dir. of SPECIFIC PHARMA A/S.
About SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.